REGRESSION OF RETINAL MICROVASCULAR ALTERATIONS IN PATIENTS WITH RHEUMATOID ARTHRITIS TREATED WITH ABATACEPT, AN INHIBITOR OF LYMPHOCYTIC CO-STIMULATION

MLA

C. De Ciuceis, et al. “Regression of Retinal Microvascular Alterations in Patients with Rheumatoid Arthritis Treated with Abatacept, an Inhibitor of Lymphocytic Co-Stimulation.” Journal of Hypertension, vol. 36, June 2018, p. e292. EBSCOhost, https://doi.org/10.1097/01.hjh.0000539854.28501.97.

APA

C. De Ciuceis, Silvia Piantoni, Angela Tincani, Paolo Airò, Claudia Rossini, D. Rizzoni, Rajesh Kumar, Stefano Caletti, C. Agabiti Rosei, & Maria Antonietta Coschignano. (2018). Regression of Retinal Microvascular Alterations in Patients with Rheumatoid Arthritis Treated with Abatacept, an Inhibitor of Lymphocytic Co-Stimulation. Journal of Hypertension, 36, e292. https://doi.org/10.1097/01.hjh.0000539854.28501.97

Chicago

C. De Ciuceis, Silvia Piantoni, Angela Tincani, Paolo Airò, Claudia Rossini, D. Rizzoni, Rajesh Kumar, Stefano Caletti, C. Agabiti Rosei, and Maria Antonietta Coschignano. 2018. “Regression of Retinal Microvascular Alterations in Patients with Rheumatoid Arthritis Treated with Abatacept, an Inhibitor of Lymphocytic Co-Stimulation.” Journal of Hypertension 36 (June): e292. doi:10.1097/01.hjh.0000539854.28501.97.